Isosorbidmononitrat Al

Isosorbide Mononitrate, the active ingredient in Isosorbidmononitrat Al, is an organic nitrate presented as an oral tablet for oral use. It is employed to prevent angina pectoris and to manage chronic stable angina in adult patients.

GNH USA supplies Isosorbidmononitrat Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isosorbide Mononitrate belongs to the organic nitrate class and is used in the management of coronary artery disease‑related angina. - Prevention of angina pectoris: reduces the frequency of anginal attacks. - Chronic stable angina: improves exercise tolerance and reduces symptom burden. - Ischemic heart disease symptom control: provides sustained vasodilation to alleviate chest pain.

Isosorbide Mononitrate may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Headache: mild to moderate, often transient. - Dizziness or light‑headedness: especially on standing. - Flushing: warm sensation of the skin. - Nausea or gastrointestinal discomfort. - Palpitations: awareness of heartbeat.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure. - Syncope: fainting episodes. - Methemoglobinemia: abnormal hemoglobin levels. - Allergic reactions: rash, pruritus, or angioedema. - Chest pain worsening: paradoxical increase in angina.

Before initiating therapy, consider the following safety measures. - Concomitant nitrate use: avoid combined use to prevent severe hypotension. - Phosphodiesterase‑5 inhibitors: contraindicated due to risk of profound blood pressure fall. - Cardiovascular instability: use cautiously in patients with recent myocardial infarction or unstable angina. - Renal or hepatic impairment: dose may need adjustment based on clinical judgment. - Pregnancy and lactation: safety not established; prescribe only if benefit outweighs risk. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Isosorbide Mononitrate can interact with several drug classes, requiring clinical vigilance.

Major Interactions (Avoid): - Other organic nitrates or nitroglycerin: additive vasodilatory effect leading to severe hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): risk of marked blood pressure reduction.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (beta‑blockers, ACE inhibitors, diuretics): may enhance blood pressure‑lowering effect. - Antiplatelet or anticoagulant therapy: monitor for increased bleeding tendency. - Alcohol: can potentiate vasodilatory side effects such as dizziness.